NZ, I will certainly send an email. Keeping shareholders as...

NZ, I will certainly send an email.

Keeping shareholders as fully informed as they can ongoing, makes them much more tolerant when things get delayed or dont go quite as planned. It displays transparency, honesty and makes shareholders feel part of the journey which in turn breeds loyalty. Now none of that helps develop a cure for Parkinsons of course, but if they need funding any time in the future both price ( impacts dlution ) and buyers ( loyalty ) will be important.

Great company, expert talent, making wonderful progress. Just need to pay some more attention to communication.

Clinical trials do take time - provides plenty of opportunity to develop and describe the "to market" success strategy should it eventuate. A fair request.! IMO